PURPOSE:To examine the global gene expression of cancer-related genes in esophageal squamous cell carcinoma (ESCC) through the use of Atlas Human Cancer Array membranes printed with 588 well-characterized human genes involved in cancer and tumor biology. EXPERIMENTAL DESIGN:Two human ESCC cell lines (HKESC-1 and HKESC-2) and one morphologically normal esophageal epithelium tissue specimen from the patient of which the HKESC-2 was derived were screened in parallel using cDNA expression arrays. The array results were additionally validated using semiquantitative PCR. The overexpression of oncogene MET was studied more extensively for its protein expression by immunohistochemistry in the two ESCC cell lines and their corresponding primary tissues and 61 primary ESCC resected specimens. Sixteen of these 61 ESCC cases also had available the corresponding morphologically normal esophageal epithelium tissues and were also analyzed for MET expression. The clinicopathological features associated with overexpression of the MET gene were also correlated. RESULTS:The results of cDNA arrays showed that 13 cancer-related genes were up-regulated > or =2-fold (CDC25B, cyclin D1, PCNA, MET, Jagged 2, Integrin alpha3, Integrin alpha6, Integrin beta4, Caveolin-2, Caveolin-1, MMP13, MMP14, and BIGH3) and 5 genes were down-regulated > or =2-fold (CK4, Bad, IGFBP2, CSPCP, and IL-1RA) in both ESCC cell lines at the mRNA level. Semiquantitative RT-PCR analysis of 9 of these differentially expressed genes, including the MET gene, gave results consistent with cDNA array findings. The immunostaining results of the expression of MET gene showed that MET was overexpressed in both ESCC cell lines and their corresponding primary tumors at the protein level, validating the cDNA arrays findings. The results of the clinical specimens showed that the MET gene was overexpressed in ESCC compared with normal esophageal epithelium in 56 of 61 cases (92%). Moreover, the overexpression of MET protein was more often seen in well/moderately differentiated than in poorly differentiated ESCC. CONCLUSIONS:Multiple cancer-related genes are differentially expressed in ESCC, the oncogene MET is overexpressed in ESCC compared with normal esophageal epithelium, and its protein overexpression correlates with tumor differentiation in ESCC.

译文

目的:通过使用Atlas Human Cancer Array膜印制了588个与癌症和肿瘤生物学有关的人类特征基因,研究了食管鳞状细胞癌(ESCC)中与癌症相关的基因的全球基因表达。
实验设计:使用cDNA表达阵列平行筛选了两个人ESCC细胞系(HKESC-1和HKESC-2)和一个形态正常的食管上皮组织标本,该标本来自于该患者的HKESC-2。使用半定量PCR进一步验证了阵列结果。通过免疫组织化学在两个ESCC细胞系及其相应的主要组织和61个主要ESCC切除的标本中对癌基因MET的过表达进行了更广泛的研究,研究了其蛋白表达。在这61例ESCC病例中,有16例具有相应的形态正常的食管上皮组织,并进行了MET表达的分析。与MET基因过表达相关的临床病理特征也相关。
结果:cDNA阵列结果显示13个与癌症相关的基因上调>或= 2倍(CDC25B,cyclin D1,PCNA,MET,锯齿状2,整合素alpha3,整合素alpha6,整合素beta4,Caveolin-2,在两种ESCC细胞系中,Caveolin-1,MMP13,MMP14和BIGH3)和5个基因在mRNA水平下调了>或= 2倍(CK4,Bad,IGFBP2,CSPCP和IL-1RA)。对这些差异表达基因中的9个(包括MET基因)进行的半定量RT-PCR分析得出的结果与cDNA阵列发现相符。 MET基因表达的免疫染色结果表明,MET在ESCC细胞系及其相应的原发性肿瘤中均在蛋白质水平上过表达,证实了cDNA阵列的发现。临床标本的结果显示,在61例患者中有56例(92%)与正常食管上皮相比,MET基因在ESCC中过表达。此外,在分化良好/中等分化的胚胎干细胞中,与分化程度低的ESCC相比,经常发现MET蛋白的过表达。
结论:与正常食管上皮相比,多种癌相关基因在食管鳞癌中差异表达,癌基因MET在食管鳞癌中过表达,其蛋白过表达与食管鳞癌的分化有关。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录